Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients Undergoing Gastroenteroscopies

Trial Profile

Effect of Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients Undergoing Gastroenteroscopies

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Esketamine (Primary) ; Remimazolam (Primary) ; Propofol
  • Indications Anxiety; Postoperative complications; Sleep disorders
  • Focus Therapeutic Use

Most Recent Events

  • 01 Sep 2024 Planned End Date changed from 10 Jun 2024 to 10 Dec 2024.
  • 01 Sep 2024 Planned primary completion date changed from 31 May 2024 to 30 Nov 2024.
  • 13 Apr 2024 Planned End Date changed from 10 Feb 2024 to 10 Jun 2024.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top